Tag: Astrazeneca

All

FDA OKs Tezspire for Severe Asthma

The FDA approved AstraZeneca and Amgen's medication, Tezspire, to treat severe asthma for patients aged 12 years and older.

COVID-19 Delta Variant May Have Increased Ability to Evade Vaccine-induced Immunity
FDA Authorizes AstraZeneca’s Long-Acting Monoclonal Antibodies
AstraZeneca Monoclonal Antibody Effective as Preventative Therapy
Mixing AstraZeneca, Pfizer Jabs Offers Protection, Study Finds
Long-term Data Shows Safety, Effectiveness of Fasenra for Severe Eosinophilic Asthma
AstraZeneca Vax 76% Effective Overall, 100% Prevention of Severe Disease
Safety Board Expresses ‘Concern’ Over AstraZeneca Vaccine Data

All

AstraZeneca COVID-19 Vaccine 79% Effective in Adults

AstraZeneca says it will submit its COVID-19 vaccination for FDA authorization after phase 3 trial results found the vaccine to be 79% effective at preventing symptomatic COVID-19 and 100% effective at preventing severe disease and hospitalization.

EU Authorizes AstraZeneca COVID-19 Vaccine
FDA Approves Tagrisso for NSC Lung Cancer
AstraZeneca Halts Phase 3 Study of COVID-19 Vaccine after Illness
AstraZeneca’s COVID-19 Vaccine Candidate Begins Phase 3 Trial
The New Medications That Could Curb Respiratory Syncytial Virus
FDA Approves Triple Therapy Breztri Aerosphere for COPD

All

Early Positive Results in Study of Oxford’s COVID-19 Vaccine

The COVID-19 vaccine being developed by Oxford University and AstraZeneca led to an immune response in roughly 1,000 patients, early study results show.

Imfinzi Trial Shows Drug Can Boost Survival Rates in LUNG Cancer Patients

Tag: Astrazeneca

All

All

All

Sorry, No Posts Found